Abstract: A method for inserting images includes the following steps. Sense a touch trace of a user forming a closed loop having an enclosed region and generating a trigger signal if the touch trace forms a closed loop having an enclosed region. Sense handwritten touch input by the user within the enclosed region and generating signals associated with the user's handwritten touch input. Display the closed loop and the sensed handwritten touch input of the user. Determine whether the sensed handwritten touch input associates with an image inserting command in response to the trigger signal. Retrieve an image selected by the user from a storage unit, if the sensed handwritten touch input associates with an image inserting command. And display the selected image within the an enclosed region of the closed loop. An electronic device using the method is also provided.

Abstract: An electronic device used for writing memos includes a storage unit, a display unit, a touch input unit, and a processor. The storage unit is used for storing an electronic calendar and a memo file written by a user. The touch input unit senses touch input of handwritten content on the displayed electronic calendar by the user and generating signals associated with the user's touch input, and recognizes handwritten content of the user according to the generating signals. The processor includes an identification module and a memo adding module. The identification module determines a date associated to the created handwritten content according to the generated signals. The memo adding module automatically adds the recognized handwritten content to the memo file stored in the storage unit of the determined date. A method for writing memos is also described.

Abstract: A method for verifying signatures includes the following steps. Generate corresponding input signals in response to user's operation for inputting a signature on an electronic device. Then detect coordinates of the handwriting of the user's signature. Extract the feature of the user's signature according to the detected coordinates. Generate a user identifier according to the extracted feature of the user's signature, and transmit the extracted feature of the user's signature and the generated user identifier to a server. Retrieve the feature of signature corresponding to the user identifier recording in the storage unit. And finally, compare the retrieved feature of signature with the received feature of the user's signature transmitted from the electronic device, to verify whether they are the same; and transmit the verified result to the electronic device. An electronic device and a signature verifying system are also provided.

Abstract: A method for controlling an exhaust-braking engine maneuver includes driving a compressor by a turbine so that the compressor receives and compresses an intake stream of fluid to produce a stream of compressed fluid. The method also includes receiving a stream of engine working fluid that includes the stream of compressed fluid, and discharging, to an exhaust system, an exhaust stream comprising the stream of engine working fluid. A stream of scavenged exhaust fluid comprising at least a portion of the exhaust stream is received, and work is extracted from the stream of scavenged exhaust fluid by the turbine to drive the compressor. The variable turbine nozzle and an intake throttle valve are modulated so as to satisfy one or more turbine control criterion and one or more compressor control criterion.

Abstract: A method of controlling a diesel engine includes sensing a speed of the diesel engine, and closing a throttle of the diesel engine when the sensed speed of the diesel engine is equal to or greater than a maximum allowable engine speed to prevent oxygen from entering an intake manifold of the diesel engine, thereby preventing combustion and stopping the operation of the diesel engine. An Exhaust Gas Recirculation (EGR) valve is actuated to regulate circulation of exhaust gas from the diesel engine through the intake manifold to control pressure within the intake manifold to prevent damage to other engine components from excessive positive or negative pressure.

Abstract: A method of controlling airflow of an engine system is provided. The method includes determining a supercharger operating mode and a turbocharger operating mode based on engine load; selectively generating a control signal to a turbocharger based on the turbocharger operating mode; and selectively generating a control signal to a supercharger bypass valve based on the supercharger operating mode.

Abstract: A control system for an engine that includes a turbocharger includes a restriction estimation module and an engine protection module. The restriction estimation module estimates restriction of airflow through an air filter of the engine based on a comparison between measured and modeled temperatures at an outlet of a compressor of the turbocharger. The engine protection module, based on the estimated airflow restriction, at least one of controls turbocharger boost, controls turbocharger airflow, controls a fueling rate of the engine, and generates a warning signal for a driver of a vehicle.

Abstract: A method and apparatus for additive range reduction are disclosed. A constant may be pre-stored in a look-up table (LUT), and at least one section of the constant may be retrieved from the LUT for generating a product of an input argument and the constant such that a precision of the product may be controlled in any granularity. For a trigonometric function, 2/? is stored in the LUT, and at least one section of 2/? may be retrieved from the LUT. The argument is multiplied with the retrieved sections of 2/?. The retrieved sections are determined to correctly generate the two least significant bits (LSBs) of an integer portion and a scalable number of most significant bits of the multiplication result. An output of the trigonometric function is generated for the argument with a fractional portion of the multiplication result based on two LSBs of the integer portion of the multiplication result.

Abstract: An intake control system comprises an estimation module and a turbocharger control module. The estimation module receives one of a first pressure within an intake manifold measured by a manifold pressure sensor and a second pressure measured by a pressure sensor at a location between a compressed air charge cooler and a throttle valve. The estimation module estimates the other one of the first and second pressures based on the received one of the first and second pressures. The turbocharger control module controls output of a turbocharger based on the estimate of the other one of the first and second pressures.

Abstract: In one exemplary embodiment of the invention, an internal combustion engine includes a turbocharger configured to receive an air flow and a first exhaust flow from the internal combustion engine and a supercharger downstream of the turbocharger configured to receive a compressed air charge from the turbocharger. The engine further includes an exhaust gas recirculation circuit receiving a second exhaust flow from the internal combustion engine and supplying the second exhaust flow to the compressed air charge upstream of the supercharger, wherein the second exhaust flow and compressed air charge comprise an exhaust-air mixed flow received by the internal combustion engine.

Abstract: A control system comprising a current control module and a force control module. The current control module selectively supplies a current to a turbine bypass valve (TBV) to adjust the TBV to a predetermined position. The force control module selectively adjusts the current in response to a determination that an actual TBV position is less than a predetermined distance from the predetermined position.

Abstract: Disclosed are compounds of Formula (I) wherein: one of A and D is —N— and the other of A and D is —C—; or enantiomers, diastereomers, or pharmaceutically-acceptable salts thereof. Also disclosed are methods of using such compounds to modulate the function of glucocorticoid receptor activity and pharmaceutical compositions comprising such compounds.

Abstract: An engine control module includes a power module and a turbine temperature module. The power module controls engine power output based on a turbine temperature. The turbine temperature module determines the turbine temperature based on a turbine inlet temperature. The power module decreases the engine power output when the turbine temperature is greater than or equal to a predetermined threshold temperature.

Abstract: Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X1, X2, X3, W, Q1, Q2, and G2 are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically acceptable salt, or hydrate, thereof, wherein X is (Ia); or X is (Ib); or X is (Ic); (Id) is heterocycle or heteroaryl; E is —N—, —NR1—, —O—, —S—, —SO2— or —CR2—; F is —N—, —NR1a—, —O—, —S—, —SO2— or —CR2a—; G is N, —NR1b—, —O—, —S—, —SO2— or —CR2b—, provided that the E-F-G containing heterocyclic ring formed does not contain a S—S or S—O bond, and at least one of E, F and G is a heteroatom; J, Ja, M, Ma, Q, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, and R3 to R21, Z, Za, Zb, and Zc are as defined above.

Abstract: An exhaust gas recirculation control system comprises a pressure condition evaluation module and a protection module. The pressure condition evaluation module evaluates at least one of vane movement of a turbocharger and engine pressure. The protection module selectively controls an exhaust gas recirculation valve based on the at least one of the vane movement of the turbocharger and the engine pressure.

Abstract: An engine control system comprises a current control module and a solenoid actuator module. The current control module determines a duty cycle based on a desired current through a solenoid of an engine system and a resistance of the solenoid and corrects the resistance based on an actual current through the solenoid. The solenoid actuator module actuates the solenoid based on the duty cycle.

Abstract: Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1, and/or NF-?B activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein (Ia) is heterocycle or heteroaryl; J, Ja, E, F, G, Ma, M, Q, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.

Abstract: Disclosed are compounds of Formula (I) wherein: one of A and D is —N— and the other of A and D is —C—; or enantiomers, diastereomers, or pharmaceutically-acceptable salts thereof. Also disclosed are methods of using such compounds to modulate the function of glucocorticoid receptor activity and pharmaceutical compositions comprising such compounds.

Abstract: A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-?B activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or (II): including a stereoisomer thereof, a tautomer thereof, a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Q is selected from N, O, and S; Y is aryl or heteroaryl; Z is H, C2-6alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, or alkoxy; and A, B, R, Ra, Rb, Rc and Rd are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.